The possible role of interleukin-16 in the low incidence of HIV infection in patients with systemic lupus erythematosus.
- Published in:
- Lupus, 2000, v. 9, n. 2, p. 155, doi. 10.1191/096120300678828136
- By:
- Publication type:
- Article
Works matching IS 09612033 AND DT 2000 AND VI 9 AND IP 2
Results: 16
1
2
Coexistence of systemic lupus erythematosus and myasthenia gravis.
- Published in:
- Lupus, 2000, v. 9, n. 2, p. 156, doi. 10.1191/096120300678828172
- By:
- Publication type:
- Article
3
The benefit of combining hydroxychloroquine with quinacrine in the treatment of SLE patients.
- Published in:
- Lupus, 2000, v. 9, n. 2, p. 92, doi. 10.1191/096120300678828082
- By:
- Publication type:
- Article
4
Is there a role for quinacrine (Atabrine) in the new millennium?
- Published in:
- Lupus, 2000, v. 9, n. 2, p. 81, doi. 10.1191/096120300678828163
- By:
- Publication type:
- Article
5
Serum levels of soluble Fas correlate with indices of organ damage in systemic lupus erythematosus.
- Published in:
- Lupus, 2000, v. 9, n. 2, p. 132, doi. 10.1191/096120300678828145
- By:
- Publication type:
- Article
6
Extensive lymphadenopathy as the first clinical manifestation in systemic lupus erythematosus.
- Published in:
- Lupus, 2000, v. 9, n. 2, p. 140, doi. 10.1191/096120300678828037
- By:
- Publication type:
- Article
7
Systemic lupus erythematosus presenting with a reticular erythematous mucinosis-like condition.
- Published in:
- Lupus, 2000, v. 9, n. 2, p. 144, doi. 10.1191/096120300678828028
- By:
- Publication type:
- Article
8
Intramedullary tuberculosis manifested as Brown—Sequard syndrome in a patient with systemic lupus erythematosus.
- Published in:
- Lupus, 2000, v. 9, n. 2, p. 147, doi. 10.1191/096120300678828064
- By:
- Publication type:
- Article
9
Thymoma associated with systemic lupus erythematosus and immunologic abnormalities.
- Published in:
- Lupus, 2000, v. 9, n. 2, p. 151, doi. 10.1191/096120300678828055
- By:
- Publication type:
- Article
10
Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis.
- Published in:
- Lupus, 2000, v. 9, n. 2, p. 101, doi. 10.1191/096120300678828046
- By:
- Publication type:
- Article
11
Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus.
- Published in:
- Lupus, 2000, v. 9, n. 2, p. 110, doi. 10.1191/096120300678828073
- By:
- Publication type:
- Article
12
Mixed cryoglobulinemia: new concepts.
- Published in:
- Lupus, 2000, v. 9, n. 2, p. 83, doi. 10.1191/096120300678828127
- By:
- Publication type:
- Article
13
The clinical features and prognosis of lupus with disease onset at age 65 and older.
- Published in:
- Lupus, 2000, v. 9, n. 2, p. 96, doi. 10.1191/096120300678828109
- By:
- Publication type:
- Article
14
ANA negative systemic lupus erythematosus sera revisited serologically.
- Published in:
- Lupus, 2000, v. 9, n. 2, p. 116, doi. 10.1191/096120300678828091
- By:
- Publication type:
- Article
15
A longitudinal study of human cytomegalovirus serology and viruria fails to detect active viral infection in 20 systemic lupus erythematosus patients.
- Published in:
- Lupus, 2000, v. 9, n. 2, p. 120, doi. 10.1191/096120300678828118
- By:
- Publication type:
- Article
16
Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis.
- Published in:
- Lupus, 2000, v. 9, n. 2, p. 127, doi. 10.1191/096120300678828154
- By:
- Publication type:
- Article